Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04543071
Title Chemo4METPANC Combination Chemotherapy in Patients With Pancreatic Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gulam Manji
Indications

pancreatic adenocarcinoma

Therapies

BKT140 + Cemiplimab + Gemcitabine + Nab-paclitaxel

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.